Ublituximab
id:
ublituximab-238-1195366
title:
Ublituximab
text:
Ublituximab, sold under the brand name Briumvi, is an immunomodulator used for the treatment of multiple sclerosis. It is a CD20-directed cytolytic monoclonal antibody. The most common adverse reactions include infusion reactions, including fever, chills, headache, influenza-like illness, elevated heart rate, nausea, throat irritation, reddening of the skin (erythema) and an anaphylactic (allergic) reaction; infections including serious and fatal bacterial, fungal, and new or reactivated viral i
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Ublituximab
date created:
date modified:
2024-02-08T04:53:14Z
main entity:
{"identifier":"Q7876570","url":"https://www.wikidata.org/entity/Q7876570"}
image:
fields total:
13
integrity:
14